2024
Reactive axillary lymph nodes after COVID-19 mRNA vaccination: comparison of mRNA vs. attenuated whole-virus vaccines
Adin M, Isufi E, Wu J, Pang Y, Nguyen D, Has D, Caner C, Aboueldaha N, Mossa-Basha M, Pucar D. Reactive axillary lymph nodes after COVID-19 mRNA vaccination: comparison of mRNA vs. attenuated whole-virus vaccines. Nuclear Medicine Communications 2024, 45: 474-480. PMID: 38465449, DOI: 10.1097/mnm.0000000000001833.Peer-Reviewed Original ResearchAxillary lymph nodesWhole virus vaccineLymph nodesMRNA vaccinesNatural courseValue of clinical parametersCOVID-19 mRNA vaccinesPredictive value of clinical parametersDose of vaccine administrationPET-CT studiesCohort of oncology patientsDeauville criteriaPET criteriaClinical parametersYounger patientsSingle doseModerna recipientsJ&J vaccinePET-positiveMultivariate analysisVaccine typesOncology patientsPredictive valueVaccine administrationModerna vaccine
2020
Clinical Impact of F-18 FDG PET-CT on Biopsy Site Selection in Patients with Suspected Bone Metastasis of Unknown Primary Site
Yoo S, Chowdhury M, Jeon S, Kang S, Lee C, Jabin Z, Kim J, Cho S, Song H, Bom H, Min J, Kwon S. Clinical Impact of F-18 FDG PET-CT on Biopsy Site Selection in Patients with Suspected Bone Metastasis of Unknown Primary Site. Nuclear Medicine And Molecular Imaging 2020, 54: 192-198. PMID: 32831965, PMCID: PMC7429616, DOI: 10.1007/s13139-020-00649-4.Peer-Reviewed Original ResearchPositron emission tomography-computed tomographySuspected bone metastasesF-18 fluorodeoxyglucoseFDG positron emission tomography-computed tomographyBone metastasesBiopsy site selectionOptimal biopsy siteBiopsy sitePrimary siteUptake lesionsF-18 FDG PET-CTChoice of biopsy siteEmission tomography-computed tomographyMetastatic bone diseaseExtra-skeletal lesionsFDG uptakeMethodsThe patientsBone biopsyClinical impactPET-positiveBiopsyBone diseaseMetastasisImaging studiesPatients
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply